José Ignacio Veytia-Bucheli, Den Alejandro Alvarado-Velázquez, Lourival Domingos Possani, Roberto González-Amaro, & Yvonne Rosenstein. (2022). The Ca<sup>2+</sup> Channel Blocker Verapamil Inhibits the In Vitro Activation and Function of T Lymphocytes: A 2022 Reappraisal. MDPI AG.
Chicago Style (17th ed.) CitationJosé Ignacio Veytia-Bucheli, Den Alejandro Alvarado-Velázquez, Lourival Domingos Possani, Roberto González-Amaro, and Yvonne Rosenstein. The Ca<sup>2+</sup> Channel Blocker Verapamil Inhibits the In Vitro Activation and Function of T Lymphocytes: A 2022 Reappraisal. MDPI AG, 2022.
MLA (9th ed.) CitationJosé Ignacio Veytia-Bucheli, et al. The Ca<sup>2+</sup> Channel Blocker Verapamil Inhibits the In Vitro Activation and Function of T Lymphocytes: A 2022 Reappraisal. MDPI AG, 2022.